10 Health Care Stocks Whale Activity In Today's Session
Guolian Securities: Increased attention to tumor immunology, recommend focusing on targeted drugs such as PD1/IL2 in pharmaceutical companies.
With the increasing attention to tumor immunity, and the successive launch of advantageous products, bullish on PD1/IL2 and PD1/IL15 targeted drugs.
Blueprint Medicines Insider Sold Shares Worth $3,905,872, According to a Recent SEC Filing
Analysts Just Shipped A Sizeable Upgrade To Their Blueprint Medicines Corporation (NASDAQ:BPMC) Estimates
Analysts' Opinions Are Mixed on These Healthcare Stocks: Blueprint Medicines (BPMC), Adaptimmune Therapeutics (ADAP) and Ardelyx (ARDX)
Form 144 | Blueprint Medicines(BPMC.US) Officer Proposes to Sell 4.32 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Aug 5, $Blueprint Medicines(BPMC.US)$ Officer Lee Philina intends to sell 46,436 shares of its common stock on Aug 5, with a total market value of approximately $4.32 million.
